Table 2.
Parameters | Details | Cases | Controls | Statistics |
---|---|---|---|---|
Group | 52 (44.1%) | 66 (55.9%) | ||
Adiponectin (μg/mL) | μ ± SD | 14.07 ± 4.69 | 13.78 ± 3.39 | MW: p = 0.774 |
M (range) | 13.57 (6.82:26.61) | 13.85 (7.05:22.31) | ||
Gμ ± SD | 13.33 ± 1.4 | 13.34 ± 1.3 | ||
Insulin resistance risk | medium-high | 10 (19.2%) | 10 (15.2%) | OR = 1.33 [0.51, 3.49] (p = 0.625) |
low | 42 (80.8%) | 56 (84.8%) | ||
TNF-alpha (pg/mL) | μ ± SD | 11.09 ± 4.21 | 7.47 ± 1.85 | MW: p < 0.001 |
M (range) | 9.7 (5.3:27.1) | 7.1 (5.6:15.5) | ||
Gμ ± SD | 10.46 ± 1.4 | 7.30 ± 1.22 | ||
Inflammation risk | high | 42 (80.8%) | 8 (12.1%) | OR = 30.45 [11.08, 83.68] (p < 0.001) |
normal | 10 (19.2%) | 58 (87.9%) |
μ ± SD = mean (standard deviation); Gμ ± SD = geometric mean (geometric standard deviation); M (range) = median (min:max); MW = Mann–Whitney test; OR/RR = odds-ratio/risk-ratio [95% CI] and p value from Fisher test).